Contamination Marketing Pharma Companies 
World of DTC Marketing
FEBRUARY 28, 2021
SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Johnson & Johnson has paid $2.7 billion in penalties.
XTalks
MAY 29, 2024
The global pharmaceutical market has been expanding at an unprecedented pace. According to Statista , in 2023, the market was estimated to be worth about $1.6 The top ten pharma companies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 billion last year, up 4.2
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Delveinsight
SEPTEMBER 8, 2021
There are several challenges faced by any company entering or persisting in the market, few of which are managerial, statistical, financial, and analytical decisions to be made by a client organization for which they would require people possessing more knowledge in the specified field that can serve as an advantage.
Pharmaceutical Technology
NOVEMBER 15, 2022
Vials can hold more doses of the vaccine, allowing for more vaccinations and a lower cost, but prefilled syringes allow for easier administration, reduced risk of contamination, minimised risk of injuries during use and improved accuracy. Cost is an important final factor, especially for small and mid-sized pharma companies.
pharmaphorum
SEPTEMBER 9, 2022
Water-borne illnesses are also likely to become more common, as increased rain and storm surges contribute to flooding and contaminated run off. Just as in the wake of COVID-19, the world will look to pharma to fulfil its public health needs. Vulnerability . Making plans is not enough.
pharmaphorum
DECEMBER 7, 2022
Pharma companies involved in the sale of heartburn therapy Zantac have won a key battle in litigation brought by patients who claim the drug caused them to develop cancer.
pharmaphorum
MARCH 22, 2022
Brian Duncan, chief operating officer of QxP, which provides the Virtuousi VR tool enabling pharma companies to train staff on manufacturing treatments, told pharmaphorum that VR is part of a longer chain that ensures that innovative and more complex therapies can be produced effectively.
Expert insights. Personalized for you.
180 
Let's personalize your content